Many aesthetic practices and medspas have already embraced video as an effective marketing tool. Videos posted on your YouTube channel and website allow you to introduce prospective patients to your staff, services and facility. They are also valuable patient-education tools. But you can take video one step further and offer virtual events that allow you to both educate and create a personal connection...
Many aesthetic practices and medspas have already embraced video as an effective...
Over the past two decades, body art has become mainstream, and this trend shows no...
new California law, the California Consumer Privacy Act of 2018 (CCPA), may affect how...
Last December the Tax Cuts and Jobs Act (TCJA) was signed into law. The new...
Canfield Scientific’s VECTRA H2 offers an all-in-one portable lightweight 3D...
Topix Pharmaceuticals' Replenix Pure Hydration Plumping Lip Treatment Broad...
Capture consistent before-and-after images with FotoFinder’s new Automated...
Epionce Renewal Calming Cream from Episciences soothes sensitive, eczema-...
 Doctors in the United States and Brazil performed the most cosmetic procedures in 2017, according to the International Society of Aesthetic Plastic Surgery (ISAPS) Global Aesthetic Survey for procedures. The survey also revealed a 5 percent increase globally in surgical cosmetic procedures...
|
 Endo International announced positive results from two Phase 3 RELEASE studies of collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks. Subjects receiving CCH showed highly statistically significant levels of improvement in the appearance of cellulite with...
|
Doctors in the United States and Brazil performed the most cosmetic procedures in 2017, according to the International Society of Aesthetic Plastic Surgery (ISAPS) Global Aesthetic Survey for procedures. The survey also revealed a 5 percent increase globally in surgical cosmetic procedures within the past 12 months.
The top five countries—U.S. (18 percent), Brazil (10.4 percent), Japan (7.2 percent), Mexico (4.4 percent) and Italy (4.1 percent)— accounted for 38.4 percent of the world’s cosmetic procedures, followed by Germany, Colombia and Thailand.
Breast augmentation was the world’s most popular cosmetic surgery at 1,677,320 procedures, followed by liposuction at 1,573,680 procedures and eyelid surgery at 1,346,886 procedures. Vaginal rejuvenation (including labiaplasty) showed the largest increase (23 percent) from 2016, followed by lower body lifts (22 percent), buttock lifts (17 percent) and rhinoplasties (11 percent). Botulinum toxin injections remained the most popular nonsurgical procedure with 5,033,693 procedures (a 1 percent increase since 2016).
Women accounted for 86.4 percent (or 20,207,190) of cosmetic procedures worldwide. Men accounted for 14.4 percent. The top five cosmetic procedures...
Endo International announced positive results from two Phase 3 RELEASE studies of collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks. Subjects receiving CCH showed highly statistically significant levels of improvement in the appearance of cellulite with treatment, as measured by the trial's primary endpoint, which was at least a two-level composite improvement in cellulite severity in the target buttock at Day 71. In addition, RELEASE-1 passed eight out of eight key secondary endpoints and RELEASE-2 passed seven out of eight key secondary endpoints.
RELEASE-1 and RELEASE-2 were identical, multicenter, randomized, double-blind, placebo-controlled studies that enrolled 845 women (423 and 422 in each separate trial) 18 years or older with moderate-to-severe cellulite. Each subject received up to three treatments of CCH (0.84mg/treatment area) or placebo spaced approximately 21 days apart. Up to twelve injections were administered during each session across each treatment area—left and right buttock. Patient and clinician used two validated photonumeric cellulite severity scales developed by Endo and third-party psychometric experts to assess cellulite severity at baseline and after...
Galderma Laboratories has received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft, a hyaluronic acid dermal filler, with a small blunt tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
The approval was based on a 16-week multicenter, open-label, prospective study of 60 male and female subjects that assessed the safety and efficacy of Restylane Lyft with lidocaine for cheek augmentation and the correction of age-related midface contour deficiencies in conjunction with the use of a small blunt tip cannula in the midface. At 16 weeks post treatment, 98.3 percent of subjects showed improvement in both the right and left midface based on the treating investigator’s assessment using the Global Aesthetic Improvement Scale (GAIS). The filler was previously approved for lip augmentation with cannula.
“I am thrilled that the FDA has approved Restylane Lyft for midface via cannula. I prefer using a cannula vs. a needle when injecting specific areas of the face,” said Anne Chapas, MD, a board certified dermatologist in New York City and clinical trial investigator for Restylane Lyft for midface injection via...
The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.
The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.
The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »
Merz Aesthetics has begun commercial shipment of the Cellfina System, indicated for long-term improvement in the appearance of cellulite in the buttocks and thighs, to aesthetic practices in the U.S.
Cellfina combines proprietary technology with minimally invasive subcision to treat the primary structural cause of dimpled cellulite. Results of the procedure last at least two years—in clinical trials, patient satisfaction with their treatment results improved from 94% at one year to 96% at the two-year mark. The most common side effects reported were soreness, tenderness and bruising... more »
